Literature DB >> 986151

Corneal neovascularization treated with argon laser.

P M Cherry, A Garner.   

Abstract

The argon laser set at 50 mum, 100-150 mW, o-2 s occluded corneal blood vessels in pigmented Dutch rabbits provided the corneal responsible for inducing vascularization was inactive. After arterial treatment with the argon laser retrograde flow in untreated veins was demonstrated by fluorescein angiography. Therefore all corneal new vessels should be treated, not just arteries. Minimal iris damage complicated the laser therapy, but this was not thought necessarily to contraindicate the use of the argon laser to treat corneal blood vessels in man. The iris damage was associated with outpouring of aqueous from the ciliary processes, and it took up to a week for the blood-aqueous barrier to return to its normal state.

Entities:  

Mesh:

Year:  1976        PMID: 986151      PMCID: PMC1017526          DOI: 10.1136/bjo.60.6.464

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  The relative absorption of thermal energy in retina and choroid.

Authors:  W J GEERAETS; R C WILLIAMS; G CHAN; W T HAM; D GUERRY; F H SCHMIDT
Journal:  Invest Ophthalmol       Date:  1962-06

2.  The response of the rabbit eye to laser irradiation of the iris.

Authors:  W G Unger; E S Perkins; M S Bass
Journal:  Exp Eye Res       Date:  1974-10       Impact factor: 3.467

3.  The ocular effects produced by experimental lasers. IV. The argon laser.

Authors:  C J Campbell; M C Rittler; C H Swope; R A Wallace
Journal:  Am J Ophthalmol       Date:  1969-05       Impact factor: 5.258

  3 in total
  5 in total

1.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  [Regression of corneal neovascularization by laser treatment? (author's transl)].

Authors:  H Baurmann; G Chioralia; F Kremer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-09-30

Review 3.  Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).

Authors:  William Stevenson; Sheng-Fu Cheng; Mohammad H Dastjerdi; Giulio Ferrari; Reza Dana
Journal:  Ocul Surf       Date:  2012-01-25       Impact factor: 5.033

4.  Corneal neovascularization in rats as a model for photothrombotic therapy using bacteriochlorin a and an argon laser.

Authors:  C A van Gool; H J Schuitmaker; M J Jager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

5.  Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival.

Authors:  Viet Nhat Hung Le; Ann-Charlott Schneider; Rebecca Scholz; Felix Bock; Claus Cursiefen
Journal:  Sci Rep       Date:  2018-04-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.